dc.contributor.author | Moran, K | en_US |
dc.contributor.author | Priebe, S | en_US |
dc.date.accessioned | 2016-02-23T15:15:09Z | |
dc.date.available | 2016-01-26 | en_US |
dc.date.issued | 2016-08 | en_US |
dc.date.submitted | 2016-01-28T15:12:22.963Z | |
dc.identifier.issn | 0962-9343 | en_US |
dc.identifier.other | QURE-D-15-00395R4 | |
dc.identifier.other | QURE-D-15-00395R4 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/11233 | |
dc.description.sponsorship | This trial was funded by the National Institute of Health Research Health Technology Assessment (Project No. 07/60/43) | en_US |
dc.format.extent | 1897 - 1902 | en_US |
dc.relation.ispartof | QUALITY OF LIFE RESEARCH | en_US |
dc.rights | • “The final publication is available at Springer via http://link.springer.com/article/10.1007/s11136-016-1238-1/fulltext.html#copyrightInformation” | |
dc.subject | Financial incentives | en_US |
dc.subject | Schizophrenia | en_US |
dc.subject | Psychosis | en_US |
dc.subject | Quality of life | en_US |
dc.subject | Adherence | en_US |
dc.subject | Anti-psychotic | en_US |
dc.title | Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money? | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1007/s11136-016-1238-1 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380005900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 8 | en_US |
pubs.notes | 6 months | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 25 | en_US |